Association of humoral antitumor response with clinical benefit in catumaxomab-treated malignant ascites patients: Results from a phase IIIb study.

被引：0
|
作者：
Ruf, Peter
Suckstorff, Ivonne
Jaeger, Michael
Ernst, Christine
Seimetz, Diane
Lindhofer, Horst
机构：
[1] TRION Res GmbH, Martinsried, Germany
[2] Fresenius Biotech GmbH, Munich, Germany
[3] TRION Res GmbH, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2584
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EpCAM plus tumor cells are detected in malignant ascites fluid with high prevalence: results from a randomized phase IIIb study
    Martinius, H.
    Biesterfeld, S.
    Seitz-Merwald, I
    Hennig, M.
    Seimetz, D.
    Boecking, A.
    ONKOLOGIE, 2011, 34 : 168 - 168
  • [22] Follow-up results from a phase II/III study of catumaxomab in patients with malignant ascites: evaluating relative lymphocyte count as a potential biomarker for overall survival
    Heiss, M.
    Stroehlein, M. A.
    Bokemeyer, C.
    Arnold, D.
    Parsons, S. L.
    Ott, M. G.
    Schulze, E.
    Lindhofer, H.
    Seimetz, D.
    Hennig, M.
    ONKOLOGIE, 2011, 34 : 169 - 170
  • [23] The role of relative lymphocyte counts for the effect of catumaxomab on overall survival in ovarian cancer patients with malignant ascites: Results from a phase 11/111 trial
    Heiss, M.
    Tschirschmann, M.
    Seimetz, D.
    Stroehlein, M.
    Hennig, M.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S88 - S88
  • [24] Dynamic Magnetic Resonance Imaging in the Assessment of the Response to Certolizumab Pegol in Rheumatoid Arthritis Patients: Results from a Phase IIIb Randomized Study.
    Ostergaard, Mikkel
    Axelsen, Mette Bjorndal
    Jacobsson, Lennart T. H.
    Schaufelberger, Christopher
    Hansen, Michael Sejer
    Bijlsma, Johannes W. J.
    Dudek, Anna
    Rell-Bakalarska, Maria
    Staelens, Fabienne
    Haake, Robert
    Sundman-Engberg, Britt
    Bliddal, Henning
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S518 - S519
  • [25] EpCAM plus Tumour Cells Are Frequently Detected in Malignant Ascites Samples- Results From a Randomized Phase IIIb CASIMas Study
    Martinius, H.
    Biesterfeld, S.
    Seitz-Merwald, I.
    Hennig, M.
    Seimetz, D.
    Boecking, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S122 - S123
  • [26] Quality-of-life assessment in patients with malignant ascites: Results of a multicenter phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.
    Gonschior, A.
    Heiss, M. M.
    Moehler, M. H.
    Parsons, S. L.
    Gilet, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Elimination of cancer stem cells (CD133+/EpCAM+) from malignant ascites by the trifunctional antibody catumaxomab: Results from a pivotal phase II/III study
    Lindhofer, H.
    Schoberth, A.
    Pelster, D.
    Hess, J.
    Herold, J.
    Jaeger, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Immunomonitoring results of a pivotal phase II/III study with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) in patients with malignant ascites
    Jaeger, M.
    Schoberth, A.
    Hennig, M.
    Burges, A.
    Heiss, M.
    Wimberger, P.
    Schmalfeldt, B.
    Lindhofer, H.
    ONKOLOGIE, 2010, 33 : 158 - 158
  • [29] Evaluation of photosensitivity in dabrafenib treated metastatic melanoma patients: Results from a phase Ila study.
    Eigentler, Thomas K.
    Ghoreschi, Kamran
    Berneburg, Mark
    Garbe, Claus
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Clinical effectiveness of Everolimus and Exemestane in advanced breast cancer patients from Asia and Africa: First efficacy and updated safety results from the phase IIIb EVEREXES study.
    Im, Young-Hyuck
    Uslu, Ruchan
    Lee, Keun Seok
    Nagarkar, Rajnish Vasant
    Sohn, Joohyuk
    Sevinc, Alper
    Altundag, Kadri
    Chang, Yuan-Ching
    Abdel-Razeq, Hikmat
    Im, Seock-Ah
    Jeong, Joon
    Park, Ho Yong
    Arpornwirat, Wichit
    Bastick, Patricia A.
    Tuan Anh Le
    Arikan, Ozlem Ocak
    Xue, Hong-Ling
    Canatar, Aycin
    Valenti, Roberta
    Kim, Sung-Bae
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345